Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:OSRHNYSE:RVPOTCMKTS:SIGYOTCMKTS:VASO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeOSRHOSR$1.17+2.6%$1.56$1.10▼$13.40$22.55M1.543.25 million shs29,258 shsRVPRetractable Technologies$0.72-4.0%$0.72$0.56▼$1.22$21.56M1.6577,312 shs54,964 shsSIGYSigyn Therapeutics$3.53$3.93$3.15▼$6.34$5.67M-1.04436 shsN/AVASOVaso$0.13+6.2%$0.13$0.11▼$0.32$23.71M1.5589,598 shs5,500 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceOSRHOSR0.00%-6.40%-12.03%+116,999,900.00%+116,999,900.00%RVPRetractable Technologies0.00%-4.05%+2.71%-9.77%-35.71%SIGYSigyn Therapeutics0.00%0.00%-14.94%-14.32%-29.40%VASOVaso0.00%-0.44%+3.77%+5.14%-43.79%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationOSRHOSRN/AN/AN/AN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AVASOVaso0.5277 of 5 stars0.03.00.00.00.81.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceOSRHOSR 0.00N/AN/AN/ARVPRetractable Technologies 0.00N/AN/AN/ASIGYSigyn Therapeutics 0.00N/AN/AN/AVASOVaso 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookOSRHOSR$4.89B0.00N/AN/AN/A∞RVPRetractable Technologies$33.05M0.65$0.01 per share48.25$3.31 per share0.22SIGYSigyn TherapeuticsN/AN/AN/AN/A($2.80) per shareN/AVASOVaso$83.05M0.29$0.03 per share4.29$0.14 per share0.96Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateOSRHOSRN/AN/A0.00∞N/AN/AN/AN/AN/ARVPRetractable Technologies-$7.01M-$0.41N/A∞N/A-41.11%-17.15%-9.33%N/ASIGYSigyn Therapeutics-$4.15M-$4.77N/A∞N/AN/AN/A-1,147.41%N/AVASOVaso$4.80MN/A0.00∞N/A-0.14%-0.45%-0.16%N/ALatest SIGY, VASO, RVP, and OSRH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025VASOVasoN/A-$0.01N/A-$0.01N/A$19.46 million4/15/2025Q4 2024SIGYSigyn TherapeuticsN/A-$2.51N/A-$2.51N/AN/A3/31/2025Q4 2024VASOVasoN/A$0.01N/A$0.01N/A$27.04 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthOSRHOSRN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/AN/AVASOVasoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioOSRHOSRN/AN/AN/ARVPRetractable Technologies0.018.575.92SIGYSigyn TherapeuticsN/A0.060.05VASOVasoN/A1.421.39Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipOSRHOSR55.30%RVPRetractable Technologies7.58%SIGYSigyn Therapeutics10.01%VASOVasoN/AInsider OwnershipCompanyInsider OwnershipOSRHOSR33.67%RVPRetractable Technologies57.10%SIGYSigyn Therapeutics78.46%VASOVaso44.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableOSRHOSRN/A19.28 million2.68 millionN/ARVPRetractable Technologies24029.94 million13.47 millionOptionableSIGYSigyn Therapeutics51.61 million346,000Not OptionableVASOVaso260175.74 million97.51 millionNot OptionableSIGY, VASO, RVP, and OSRH HeadlinesRecent News About These CompaniesVaso Corporation Announces Financial Results for First Quarter of 2025May 15 at 9:00 AM | globenewswire.comNew tapas and wine bar to open in Nottingham from the team behind MesaMay 6, 2025 | msn.comHe compared him to Justin Bieber, but he got what he deserved in the ringApril 24, 2025 | msn.comThe Zacks Analyst Blog Highlights Apple, Philip Morris International, Sony and VasoApril 21, 2025 | uk.finance.yahoo.comC-Reactive Protein Increases During Menstrual Cycle in Females With Sickle Cell DiseaseApril 18, 2025 | rheumatologyadvisor.comTop Analyst Reports for Apple, Philip Morris & SonyApril 17, 2025 | finance.yahoo.comShake up your Monday: VASO hosts an electrifying cocktail showdown with top bartendersApril 17, 2025 | myfox28columbus.comInflammation during menstrual cycle may trigger VOEs: StudyApril 15, 2025 | sicklecellanemianews.comDangerous 'crises' in sickle cell disease may be amplified by menstrual cycleApril 14, 2025 | msn.comVASO Stock Rises Post Q4 Revenue Growth and Solid Segment GainsApril 7, 2025 | zacks.comVasomedical reports Q4 revenue $27M vs. $21.9M last yearApril 1, 2025 | markets.businessinsider.comVaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024March 31, 2025 | markets.businessinsider.comCORRECTION - Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024March 31, 2025 | globenewswire.comVASO to host debut igloo decorating competition in honor of Women's History MonthMarch 21, 2025 | msn.comMeet The First Man In New York's History To Be Cured Of Sickle Cell DiseaseMarch 18, 2025 | msn.comApproved Sickle Cell Drug Fails to Beat Placebo in TrialMarch 14, 2025 | medpagetoday.comLocal breweries to host events for International Women's DayMarch 7, 2025 | msn.comVirginia youth compete in state STEM competition at Mary WashingtonMarch 7, 2025 | augustafreepress.comIncidence of sickle cell disease complications rise in cold weatherFebruary 25, 2025 | sicklecellanemianews.comSickle Cell Trait Not Linked to Exertion-Related Death, Study FindsFebruary 21, 2025 | emjreviews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSIGY, VASO, RVP, and OSRH Company DescriptionsOSR NASDAQ:OSRH$1.17 +0.03 (+2.63%) As of 05/16/2025 03:59 PM EasternOSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.Retractable Technologies NYSE:RVP$0.72 -0.03 (-4.00%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$0.74 +0.02 (+2.08%) As of 05/16/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.Sigyn Therapeutics OTCMKTS:SIGY$3.53 0.00 (0.00%) As of 05/16/2025Sigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the potential efficacy of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California.Vaso OTCMKTS:VASO$0.13 +0.01 (+6.22%) As of 05/16/2025 03:59 PM EasternVaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/12 - 05/16 Retail Investors Are Betting Big on Rocket Lab—Should You Too? Meta's 5 Key Pillars for AI Growth—Zuckerberg's Bold Vision Taiwan Semiconductor Stock Is The Gift That Keeps on Giving GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine Alibaba's Earnings Just Changed Everything for the Stock Plug Power: Is Q1 Noise An Opportunity for Accumulation? Cisco Stock Eyes New Highs in 2025 on AI, Earnings, Upgrades Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
